| |
When Is Evidence Sufficient?
Karl Claxton,
Joshua T. Cohen and
Peter J. Neumann
Traditional conceptualizations of evidence-based medicine rely heavily on randomized controlled trials. Although initiatives to broaden definitions of evidence have been advanced, they generally have not tied evidentiary criteria formally and quantitatively to the benefits and costs involved in a decision to adopt or reject an intervention. Decision analysis provides a framework for combining information to inform the adoption decision in this manner. Value-of-information analysis, a related methodology, helps to determine whether it is worthwhile to collect additional information as well as the type of research that would be most helpful.

What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. S. Braithwaite and A. B. Rosen
Pitfalls in Linking Cost Sharing to Value
Ann Intern Med,
February 5, 2008;
148(3):
244 - 244.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Mansley, E. H. Elbasha, S. M. Teutsch, and M. L. Berger
The Decision to Conduct a Head-to-Head Comparative Trial: A Game-Theoretic Analysis
Med Decis Making,
August 1, 2007;
27(4):
364 - 379.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Cohen and P. J. Neumann
What's More Dangerous, Your Aspirin Or Your Car? Thinking Rationally About Drug Risks (And Benefits)
Health Aff.,
May 1, 2007;
26(3):
636 - 646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Neumann
Challenges Ahead For Federal Technology Assessment
Health Aff.,
March 1, 2007;
26(2):
w150 - w152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Neumann
Emerging Lessons From The Drug Effectiveness Review Project
Health Aff.,
July 1, 2006;
25(4):
W262 - W271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Neumann, N. Divi, M. T. Beinfeld, B.-S. Levine, P. S. Keenan, E. F. Halpern, and G. S. Gazelle
Medicare's National Coverage Decisions, 1999-2003: Quality Of Evidence And Review Times
Health Aff.,
January 1, 2005;
24(1):
243 - 254.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|